Apollo Medical Holdings Inc (NASDAQ:AMEH) has received an average broker rating score of 2.00 (Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a buy recommendation.
Analysts have set a one year consensus price target of $25.00 for the company and are predicting that the company will post $0.08 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Apollo Medical an industry rank of 189 out of 255 based on the ratings given to related companies.
A number of equities research analysts have recently commented on the stock. Zacks Investment Research cut shares of Apollo Medical from a “hold” rating to a “sell” rating in a research note on Friday, March 29th. ValuEngine raised shares of Apollo Medical from a “hold” rating to a “buy” rating in a research note on Monday, February 25th.
Shares of NASDAQ AMEH opened at $18.84 on Friday. The company has a market cap of $674.81 million, a PE ratio of 64.97, a PEG ratio of 5.54 and a beta of -1.17. Apollo Medical has a 12 month low of $13.01 and a 12 month high of $30.00. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.40 and a current ratio of 2.40.
Apollo Medical Company Profile
Apollo Medical Holdings, Inc, an integrated health care delivery and management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Further Reading: Cash Flow Analysis in Stock Selection
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.